TABLE 4

Univariate and Multivariate Analyses

Univariate analysisMultivariate analysis
PredictorCategoryOverall survivalHazard ratioPHazard ratioP
Age (y)<657.8 (5.8–11)0.9 (0.6–1.2)0.49NANA
≥657.5 (5–9.4)1NA
SexFemale9.5 (5.3–13.7)0.9 (0.6–1.3)0.6NANA
Male7.3 (5.8–8.5)1NA
Albumin>3.5 g/dL11.7–210.4 (0.2–0.7)0.0020.7 (0.4–1.4)0.3
2.8–3.5 g/dL7.8 (6.4–11.4)0.7 (0.5–0.9)0.7 (0.5–1)0.07
<2.8 g/dL4.8 (4–7.7)11
Bilirubin<2 mg/dL8 (7.3–11)0.15 (0.03–0.6)<0.00010.16 (0.07–0.3)<0.0001
2–3 mg/dL5 (2.2–9.7)0.24 (0.05–1.2)0.18 (0.07–0.43)0.0001
>3 mg/dL2 (1.2–3)11
CirrhosisAbsent6.8 (6.2–8.9)0.95 (0.6–1.6)0.86NANA
Present7.7 (5–20)1NA
AscitesAbsent8.8 (7.7–12)0.6 (0.4–0.85)0.00150.6 (0.4–0.9)0.01
Present4.6 (3.5–6.4)11
Baseline tumor size≤5 cm13.9 (11–20)0.5 (0.4–0.75)0.00070.64 (0.42–0.97)0.037
>5 cm6.4 (5–7.8)11
Number of lesionsSolitary12.6 (7.7–19)0.6 (0.4–0.78)0.0010.62 (0.4–0.98)0.04
Multifocal6.5 (5–7.9)11
InfiltrationNoninfiltrative12.6 (7.7–14)0.67 (0.5–0.9)0.011 (0.7–1.5)0.9
Infiltrative tumor6.2 (4.6–7.7)11
Tumor distributionUnilobar9.4 (7.7–13.3)0.6 (0.4–0.8)0.00150.68 (0.46–1)0.068
Bilobar5 (4.5–6.5)11
AFP<10011.4 (7.9–13.9)0.7 (0.5–0.9)0.050.67 (0.5–0.96)0.03
≥1006.5 (5–7.7)11
ECOG08 (6.7–13.8)0.32 (0.14–0.78)0.00010.44 (0.24–0.8)0.01
17.7 (5.2–9.5)0.35 (0.15–0.8)0.39 (0.22–0.7)0.001
22.5 (2–4.6)11
PVT extentSegmental13.8 (8.5–15.7)0.54 (0.36–0.8)0.0080.8 (0.5–1.3)0.4
Lobar7.7 (5.3–10.4)0.7 (0.5–1)0.8 (0.5–1.2)0.2
Main5 (4–7.7)11
  • NA = not applicable; ECOG = Eastern Cooperative Oncology Group.

  • Data in parentheses are 95% CI.